In Vivo and in Vitro Experimental Study on Cervix Cancer with Combination of HSV-TK/GCV Suicide Gene Therapy System and 60 Co Radiotherapy

Daozhen Chen,Qiusha Tang

DOI: https://doi.org/10.3760/cma.j.issn.0254-5098.2006.01.013

2006-01-01

Abstract:Objective To evaluate the killing effect of HSV-TK/GCV suicide gene therapy system combined with ~(60)Co radiotherapy on human cervical cancer HeLa cell line in vivo and in vitro, and to explore radiosensitization by the HSV-TK/GCV system. Methods The HSV-TK/GCV suicide gene therapy system and ~(60)Co radiotherapy were used separately or in combination for human cervical cancer HeLa cell line in vivo and in vitro to compare their effects.Colony formation test and the rate of radiosensitization effect(E/O)were employed to observed the radiosensitization by the HSV-TK/GCV system. Results The HSV-TK/GCV suicide gene therapy system showed strong therapeutic effects on HeLa cells both in vitro and in vivo(the inhibition rates were 45.8% and 39.5%,respectively).Moreover,the combined application of gene therapy and radiotherapy exhibited stronger therapeutic effects in vitro and in vivo(the inhibition rate was 87.5% in vitro,and was 87.9% in vivo)(P0.01).The inhibition rate of radiotherapy alone was 42.4% in vitro and 35.8% in vivo.The sensitivity to radiotherapy in combined therapy increased more than that of either therapy alone,and the ability of colony formation decreased(P0.01).The rate of radiosensitization effect(E/O)was 3.2(1.4),indicating the HSV-TK/GCV system could exert a sensitizing effect on ~(60)Co radiotherapy of the transplanted human cervical cancer cells in nude mice. Conclusion The HSV-TK/GCV system has radiosensitizationaction.Gene therapy combined with radiotherapy may be a good supplementary method for synthetic treatment of cervical cancer.